Home > Formulary : Adult > Recent Decisions > 2019 >
Decisions 2nd April 2019
At the meeting on the 2nd April the following decisions were agreed:
New Drug Requests
Approved
Melatonin (Red)
- Approved for REM Sleep Behaviour disorder (SCP pending)
Semaglutide
- Approved for insufficiently controlled type 2 diabetes
Alprostadil urethral cream (Vitaros®) (Amber NO SCP)
- Approved for erectile dysfunction
Mydrane injection
- Approved for cataract surgery
Further work needed
Mercaptopurine
- For Autoimmune Hepatitis who are intolerant of azathioprine. The group had questions that needed answering before a decision can be made.
Shared Care Protocols/TLS change in status
Dronedarone SCP
- Approved up dated SCP